May 11, 1998

Donepezil Improves Cognition and Global Function in Alzheimer DiseaseA 15-Week, Double-blind, Placebo-Controlled Study

SRSharon L. RogersUniversity of Nevada, Las Vegas

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

Donepezil hydrochloride (5 and 10 mg) administered once daily is a well-tolerated and efficacious agent for treating the symptoms of mild to moderately severe Alzheimer disease.

Preguntar a la IA

Me gusta

Guardar

Ver artículo completo

Cite This Study

Sharon L. Rogers (Mon,) studied this question.

synapsesocial.com/papers/69d8139605ee2ba81dbeef42 https://doi.org/https://doi.org/10.1001/archinte.158.9.1021

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1“Mini-mental state”1975 · 87,027 citations
2Synthesis and structure-activity relationships of acetylcholinesterase inhibitors: 1-benzyl-4-(2-phthalimidoethyl)piperidine, and related derivatives1992 · 64 citations
3Quality of life, social indicators, and criteria of change.1977 · 81 citations
4Clinical predictors of course for Alzheimer patients in a longitudinal study: a preliminary report.1988 · 84 citations
5Cholinergic therapies for Alzheimer's disease. Palliative or disease altering?1995 · 24 citations

Preguntar a la IA

Me gusta

Guardar

Ver artículo completo